APO Research
Talk to an analyst

APO RESEARCH · REPORT

VR Therapy Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global VR Therapy Software Market Outlook and Growth Opportunities 2026

4 January 2026213 pages

Choose your research edition.

Industry ResearchVR Therapy Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal VR Therapy Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal VR Therapy Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal VR Therapy Software Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal VR Therapy Software Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global VR Therapy Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for VR Therapy Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for VR Therapy Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for VR Therapy Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the VR Therapy Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the VR Therapy Software market include RecoveryVR, XRHealth, Corpus VR, oVRcome, C2Care, Guided VR, InMotion VR, Limbix and Oxford VR, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global VR Therapy Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of VR Therapy Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents VR Therapy Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global VR Therapy Software market.

VR Therapy Software Segment by Company

RecoveryVR

XRHealth

Corpus VR

oVRcome

C2Care

Guided VR

InMotion VR

Limbix

Oxford VR

Happinss VR

Rendever

AppliedVR

Virtualis VR

In Virtuo

KineQuantum

PsyTech VR

Rocket VR Health

KindVR

Rehametrics

Firsthand

LibraVR

Psylaris

VR Therapy Software Segment by Type

Cloud-based

Local Deployment

VR Therapy Software Segment by Application

Mental Health Therapy

Rehabilitation Medicine

Pain Management

Medical Education

Other

VR Therapy Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global VR Therapy Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the VR Therapy Software key companies, revenue, market share, and recent developments.

3. To split the VR Therapy Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions VR Therapy Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify VR Therapy Software significant trends, drivers, influence factors in global and regions.

6. To analyze VR Therapy Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global VR Therapy Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of VR Therapy Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of VR Therapy Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global VR Therapy Software industry.

Chapter 3: Detailed analysis of VR Therapy Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of VR Therapy Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of VR Therapy Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. VR Therapy Software Industry Trends Table 2. VR Therapy Software Industry Drivers Table 3. VR Therapy Software Industry Opportunities and Challenges Table 4. VR Therapy Software Industry Restraints Table 5. Global VR Therapy Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global VR Therapy Software Revenue Share by Company (2021-2026) Table 7. Global VR Therapy Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global VR Therapy Software Key Company Manufacturing Base & Headquarters Table 9. Global VR Therapy Software Company, Product Type & Application Table 10. Global VR Therapy Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global VR Therapy Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of Local Deployment Table 16. Global VR Therapy Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global VR Therapy Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global VR Therapy Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global VR Therapy Software Sales Value Share by Type (2021-2026) Table 20. Global VR Therapy Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Mental Health Therapy Table 22. Significant Companies of Rehabilitation Medicine Table 23. Significant Companies of Pain Management Table 24. Significant Companies of Medical Education Table 25. Significant Companies of Other Table 26. Global VR Therapy Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global VR Therapy Software Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global VR Therapy Software Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global VR Therapy Software Sales Value Share by Application (2021-2026) Table 30. Global VR Therapy Software Sales Value Share by Application (2027-2032) Table 31. Global VR Therapy Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global VR Therapy Software Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global VR Therapy Software Sales Value Share by Region (2021-2026) Table 34. Global VR Therapy Software Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global VR Therapy Software Sales Value Share by Region (2027-2032) Table 36. Global VR Therapy Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global VR Therapy Software Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global VR Therapy Software Sales Value Market Share by Country (2021-2026) Table 39. Global VR Therapy Software Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global VR Therapy Software Sales Value Market Share by Country (2027-2032) Table 41. RecoveryVR Company Information Table 42. RecoveryVR Business Overview Table 43. RecoveryVR VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. RecoveryVR VR Therapy Software Product Portfolio Table 45. RecoveryVR Recent Development Table 46. XRHealth Company Information Table 47. XRHealth Business Overview Table 48. XRHealth VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. XRHealth VR Therapy Software Product Portfolio Table 50. XRHealth Recent Development Table 51. Corpus VR Company Information Table 52. Corpus VR Business Overview Table 53. Corpus VR VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Corpus VR VR Therapy Software Product Portfolio Table 55. Corpus VR Recent Development Table 56. oVRcome Company Information Table 57. oVRcome Business Overview Table 58. oVRcome VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. oVRcome VR Therapy Software Product Portfolio Table 60. oVRcome Recent Development Table 61. C2Care Company Information Table 62. C2Care Business Overview Table 63. C2Care VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. C2Care VR Therapy Software Product Portfolio Table 65. C2Care Recent Development Table 66. Guided VR Company Information Table 67. Guided VR Business Overview Table 68. Guided VR VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Guided VR VR Therapy Software Product Portfolio Table 70. Guided VR Recent Development Table 71. InMotion VR Company Information Table 72. InMotion VR Business Overview Table 73. InMotion VR VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. InMotion VR VR Therapy Software Product Portfolio Table 75. InMotion VR Recent Development Table 76. Limbix Company Information Table 77. Limbix Business Overview Table 78. Limbix VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Limbix VR Therapy Software Product Portfolio Table 80. Limbix Recent Development Table 81. Oxford VR Company Information Table 82. Oxford VR Business Overview Table 83. Oxford VR VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Oxford VR VR Therapy Software Product Portfolio Table 85. Oxford VR Recent Development Table 86. Happinss VR Company Information Table 87. Happinss VR Business Overview Table 88. Happinss VR VR Therapy Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Happinss VR VR Therapy Software Product Portfolio Table 90. Happinss VR Recent Development Table 91. Rendever Company Information Table 92. Rendever Business Overview Table 93. Rendever VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Rendever VR Therapy Software Product Portfolio Table 95. Rendever Recent Development Table 96. AppliedVR Company Information Table 97. AppliedVR Business Overview Table 98. AppliedVR VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. AppliedVR VR Therapy Software Product Portfolio Table 100. AppliedVR Recent Development Table 101. Virtualis VR Company Information Table 102. Virtualis VR Business Overview Table 103. Virtualis VR VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Virtualis VR VR Therapy Software Product Portfolio Table 105. Virtualis VR Recent Development Table 106. In Virtuo Company Information Table 107. In Virtuo Business Overview Table 108. In Virtuo VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. In Virtuo VR Therapy Software Product Portfolio Table 110. In Virtuo Recent Development Table 111. KineQuantum Company Information Table 112. KineQuantum Business Overview Table 113. KineQuantum VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. KineQuantum VR Therapy Software Product Portfolio Table 115. KineQuantum Recent Development Table 116. PsyTech VR Company Information Table 117. PsyTech VR Business Overview Table 118. PsyTech VR VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. PsyTech VR VR Therapy Software Product Portfolio Table 120. PsyTech VR Recent Development Table 121. Rocket VR Health Company Information Table 122. Rocket VR Health Business Overview Table 123. Rocket VR Health VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Rocket VR Health VR Therapy Software Product Portfolio Table 125. Rocket VR Health Recent Development Table 126. KindVR Company Information Table 127. KindVR Business Overview Table 128. KindVR VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. KindVR VR Therapy Software Product Portfolio Table 130. KindVR Recent Development Table 131. Rehametrics Company Information Table 132. Rehametrics Business Overview Table 133. Rehametrics VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Rehametrics VR Therapy Software Product Portfolio Table 135. Rehametrics Recent Development Table 136. Firsthand Company Information Table 137. Firsthand Business Overview Table 138. Firsthand VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Firsthand VR Therapy Software Product Portfolio Table 140. Firsthand Recent Development Table 141. LibraVR Company Information Table 142. LibraVR Business Overview Table 143. LibraVR VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. LibraVR VR Therapy Software Product Portfolio Table 145. LibraVR Recent Development Table 146. Psylaris Company Information Table 147. Psylaris Business Overview Table 148. Psylaris VR Therapy Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Psylaris VR Therapy Software Product Portfolio Table 150. Psylaris Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. VR Therapy Software Product Image Figure 2. Global VR Therapy Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global VR Therapy Software Market Size (2021-2032) & (US$ Million) Figure 4. Global VR Therapy Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. Local Deployment Image Figure 9. Global VR Therapy Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global VR Therapy Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global VR Therapy Software Sales Value Share by Type (2021-2032) Figure 12. Mental Health Therapy Image Figure 13. Rehabilitation Medicine Image Figure 14. Pain Management Image Figure 15. Medical Education Image Figure 16. Other Image Figure 17. Global VR Therapy Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global VR Therapy Software Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global VR Therapy Software Sales Value Share by Application (2021-2032) Figure 20. Global VR Therapy Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global VR Therapy Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America VR Therapy Software Sales Value (2021-2032) & (US$ Million) Figure 23. North America VR Therapy Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe VR Therapy Software Sales Value (2021-2032) & (US$ Million) Figure 25. Europe VR Therapy Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific VR Therapy Software Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific VR Therapy Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America VR Therapy Software Sales Value (2021-2032) & (US$ Million) Figure 29. South America VR Therapy Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa VR Therapy Software Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa VR Therapy Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt VR Therapy Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt VR Therapy Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt VR Therapy Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • Local Deployment
Applications
  • Mental Health Therapy
  • Rehabilitation Medicine
  • Pain Management
  • Medical Education
  • Other
Companies covered
  • RecoveryVR
  • XRHealth
  • Corpus VR
  • oVRcome
  • C2Care
  • Guided VR
  • InMotion VR
  • Limbix
  • Oxford VR
  • Happinss VR
  • Rendever
  • AppliedVR
  • Virtualis VR
  • In Virtuo
  • KineQuantum
  • PsyTech VR
  • Rocket VR Health
  • KindVR
  • Rehametrics
  • Firsthand
  • LibraVR
  • Psylaris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global VR Therapy Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global VR Therapy Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 VR Therapy Software Market Dynamics
  1. 2.1 VR Therapy Software Industry Trends
  2. 2.2 VR Therapy Software Industry Drivers
  3. 2.3 VR Therapy Software Industry Opportunities and Challenges
  4. 2.4 VR Therapy Software Industry Restraints
3 VR Therapy Software Market by Company
  1. 3.1 Global VR Therapy Software Company Revenue Ranking in 2025
  2. 3.2 Global VR Therapy Software Revenue by Company (2021-2026)
  3. 3.3 Global VR Therapy Software Company Ranking (2024-2026)
  4. 3.4 Global VR Therapy Software Company Manufacturing Base and Headquarters
  5. 3.5 Global VR Therapy Software Company Product Type and Application
  6. 3.6 Global VR Therapy Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global VR Therapy Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 VR Therapy Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 VR Therapy Software Market by Type
  1. 4.1 VR Therapy Software Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 Local Deployment
  4. 4.2 Global VR Therapy Software Sales Value by Type
  5. 4.2.1 Global VR Therapy Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global VR Therapy Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global VR Therapy Software Sales Value Share by Type (2021-2032)
5 VR Therapy Software Market by Application
  1. 5.1 VR Therapy Software Application Introduction
  2. 5.1.1 Mental Health Therapy
  3. 5.1.2 Rehabilitation Medicine
  4. 5.1.3 Pain Management
  5. 5.1.4 Medical Education
  6. 5.1.5 Other
  7. 5.2 Global VR Therapy Software Sales Value by Application
  8. 5.2.1 Global VR Therapy Software Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global VR Therapy Software Sales Value by Application (2021-2032)
  10. 5.2.3 Global VR Therapy Software Sales Value Share by Application (2021-2032)
6 VR Therapy Software Regional Value Analysis
  1. 6.1 Global VR Therapy Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global VR Therapy Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global VR Therapy Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global VR Therapy Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America VR Therapy Software Sales Value (2021-2032)
  7. 6.3.2 North America VR Therapy Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe VR Therapy Software Sales Value (2021-2032)
  10. 6.4.2 Europe VR Therapy Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific VR Therapy Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific VR Therapy Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America VR Therapy Software Sales Value (2021-2032)
  16. 6.6.2 South America VR Therapy Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa VR Therapy Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa VR Therapy Software Sales Value Share by Country, 2025 VS 2032
7 VR Therapy Software Country-level Value Analysis
  1. 7.1 Global VR Therapy Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global VR Therapy Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global VR Therapy Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global VR Therapy Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA VR Therapy Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada VR Therapy Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico VR Therapy Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany VR Therapy Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France VR Therapy Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. VR Therapy Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy VR Therapy Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain VR Therapy Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia VR Therapy Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands VR Therapy Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries VR Therapy Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China VR Therapy Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan VR Therapy Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea VR Therapy Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India VR Therapy Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia VR Therapy Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia VR Therapy Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil VR Therapy Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina VR Therapy Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile VR Therapy Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia VR Therapy Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru VR Therapy Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia VR Therapy Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel VR Therapy Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE VR Therapy Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey VR Therapy Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran VR Therapy Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran VR Therapy Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt VR Therapy Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt VR Therapy Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt VR Therapy Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RecoveryVR
  2. 8.1.1 RecoveryVR Company Information
  3. 8.1.2 RecoveryVR Business Overview
  4. 8.1.3 RecoveryVR VR Therapy Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 RecoveryVR VR Therapy Software Product Portfolio
  6. 8.1.5 RecoveryVR Recent Developments
  7. 8.2 XRHealth
  8. 8.2.1 XRHealth Company Information
  9. 8.2.2 XRHealth Business Overview
  10. 8.2.3 XRHealth VR Therapy Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 XRHealth VR Therapy Software Product Portfolio
  12. 8.2.5 XRHealth Recent Developments
  13. 8.3 Corpus VR
  14. 8.3.1 Corpus VR Company Information
  15. 8.3.2 Corpus VR Business Overview
  16. 8.3.3 Corpus VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Corpus VR VR Therapy Software Product Portfolio
  18. 8.3.5 Corpus VR Recent Developments
  19. 8.4 oVRcome
  20. 8.4.1 oVRcome Company Information
  21. 8.4.2 oVRcome Business Overview
  22. 8.4.3 oVRcome VR Therapy Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 oVRcome VR Therapy Software Product Portfolio
  24. 8.4.5 oVRcome Recent Developments
  25. 8.5 C2Care
  26. 8.5.1 C2Care Company Information
  27. 8.5.2 C2Care Business Overview
  28. 8.5.3 C2Care VR Therapy Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 C2Care VR Therapy Software Product Portfolio
  30. 8.5.5 C2Care Recent Developments
  31. 8.6 Guided VR
  32. 8.6.1 Guided VR Company Information
  33. 8.6.2 Guided VR Business Overview
  34. 8.6.3 Guided VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guided VR VR Therapy Software Product Portfolio
  36. 8.6.5 Guided VR Recent Developments
  37. 8.7 InMotion VR
  38. 8.7.1 InMotion VR Company Information
  39. 8.7.2 InMotion VR Business Overview
  40. 8.7.3 InMotion VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 InMotion VR VR Therapy Software Product Portfolio
  42. 8.7.5 InMotion VR Recent Developments
  43. 8.8 Limbix
  44. 8.8.1 Limbix Company Information
  45. 8.8.2 Limbix Business Overview
  46. 8.8.3 Limbix VR Therapy Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Limbix VR Therapy Software Product Portfolio
  48. 8.8.5 Limbix Recent Developments
  49. 8.9 Oxford VR
  50. 8.9.1 Oxford VR Company Information
  51. 8.9.2 Oxford VR Business Overview
  52. 8.9.3 Oxford VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Oxford VR VR Therapy Software Product Portfolio
  54. 8.9.5 Oxford VR Recent Developments
  55. 8.10 Happinss VR
  56. 8.10.1 Happinss VR Company Information
  57. 8.10.2 Happinss VR Business Overview
  58. 8.10.3 Happinss VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Happinss VR VR Therapy Software Product Portfolio
  60. 8.10.5 Happinss VR Recent Developments
  61. 8.11 Rendever
  62. 8.11.1 Rendever Company Information
  63. 8.11.2 Rendever Business Overview
  64. 8.11.3 Rendever VR Therapy Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Rendever VR Therapy Software Product Portfolio
  66. 8.11.5 Rendever Recent Developments
  67. 8.12 AppliedVR
  68. 8.12.1 AppliedVR Company Information
  69. 8.12.2 AppliedVR Business Overview
  70. 8.12.3 AppliedVR VR Therapy Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AppliedVR VR Therapy Software Product Portfolio
  72. 8.12.5 AppliedVR Recent Developments
  73. 8.13 Virtualis VR
  74. 8.13.1 Virtualis VR Company Information
  75. 8.13.2 Virtualis VR Business Overview
  76. 8.13.3 Virtualis VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Virtualis VR VR Therapy Software Product Portfolio
  78. 8.13.5 Virtualis VR Recent Developments
  79. 8.14 In Virtuo
  80. 8.14.1 In Virtuo Company Information
  81. 8.14.2 In Virtuo Business Overview
  82. 8.14.3 In Virtuo VR Therapy Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 In Virtuo VR Therapy Software Product Portfolio
  84. 8.14.5 In Virtuo Recent Developments
  85. 8.15 KineQuantum
  86. 8.15.1 KineQuantum Company Information
  87. 8.15.2 KineQuantum Business Overview
  88. 8.15.3 KineQuantum VR Therapy Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 KineQuantum VR Therapy Software Product Portfolio
  90. 8.15.5 KineQuantum Recent Developments
  91. 8.16 PsyTech VR
  92. 8.16.1 PsyTech VR Company Information
  93. 8.16.2 PsyTech VR Business Overview
  94. 8.16.3 PsyTech VR VR Therapy Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 PsyTech VR VR Therapy Software Product Portfolio
  96. 8.16.5 PsyTech VR Recent Developments
  97. 8.17 Rocket VR Health
  98. 8.17.1 Rocket VR Health Company Information
  99. 8.17.2 Rocket VR Health Business Overview
  100. 8.17.3 Rocket VR Health VR Therapy Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Rocket VR Health VR Therapy Software Product Portfolio
  102. 8.17.5 Rocket VR Health Recent Developments
  103. 8.18 KindVR
  104. 8.18.1 KindVR Company Information
  105. 8.18.2 KindVR Business Overview
  106. 8.18.3 KindVR VR Therapy Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 KindVR VR Therapy Software Product Portfolio
  108. 8.18.5 KindVR Recent Developments
  109. 8.19 Rehametrics
  110. 8.19.1 Rehametrics Company Information
  111. 8.19.2 Rehametrics Business Overview
  112. 8.19.3 Rehametrics VR Therapy Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Rehametrics VR Therapy Software Product Portfolio
  114. 8.19.5 Rehametrics Recent Developments
  115. 8.20 Firsthand
  116. 8.20.1 Firsthand Company Information
  117. 8.20.2 Firsthand Business Overview
  118. 8.20.3 Firsthand VR Therapy Software Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Firsthand VR Therapy Software Product Portfolio
  120. 8.20.5 Firsthand Recent Developments
  121. 8.21 LibraVR
  122. 8.21.1 LibraVR Company Information
  123. 8.21.2 LibraVR Business Overview
  124. 8.21.3 LibraVR VR Therapy Software Revenue and Gross Margin (2021-2026)
  125. 8.21.4 LibraVR VR Therapy Software Product Portfolio
  126. 8.21.5 LibraVR Recent Developments
  127. 8.22 Psylaris
  128. 8.22.1 Psylaris Company Information
  129. 8.22.2 Psylaris Business Overview
  130. 8.22.3 Psylaris VR Therapy Software Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Psylaris VR Therapy Software Product Portfolio
  132. 8.22.5 Psylaris Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst